Pfizer

PFE · United States · Pharmaceuticals · matched S&P 500 member. Follow its market-weight contribution.

Historical time machine

Historical observation

20182026

Universe weight

0.382%

12M weight contribution

-0.244 pp

3M weight contribution

+0.085 pp

12M price return

-7.6%

Share of matched S&P 500 members

Monthly observations through Sep 2024

Company price index

A separate dimension from market allocation

Historical observations

Most recent 24 observations at or before the selected month

Month	Market cap	Universe weight	12M weight change	12M return	Above 6M weight average
Sep 2024	$164.0bn	0.382%	-0.244 pp	-7.6%	Yes
Aug 2024	$164.4bn	0.397%	-0.239 pp	-13.2%	Yes
Jul 2024	$173.1bn	0.310%	-0.134 pp	-10.3%	No
Jun 2024	$158.6bn	0.297%	-0.182 pp	-19.5%	No
May 2024	$162.4bn	0.310%	-0.220 pp	-20.4%	No
Apr 2024	$144.7bn	0.419%	-0.319 pp	-30.7%	No
Mar 2024	$156.7bn	0.435%	-0.348 pp	-28.5%	No
Feb 2024	$150.0bn	0.430%	-0.372 pp	-31.2%	No
Jan 2024	$152.9bn	0.455%	-0.394 pp	-35.5%	No
Dec 2023	$162.6bn	0.485%	-0.553 pp	-41.3%	No
Nov 2023	$172.0bn	0.536%	-0.419 pp	-36.5%	No
Oct 2023	$172.5bn	0.587%	-0.341 pp	-31.7%	Yes
Sep 2023	$187.3bn	0.625%	-0.340 pp	-21.1%	Yes
Aug 2023	$199.8bn	0.637%	-0.272 pp	-18.6%	Yes
Jul 2023	$203.6bn	0.444%	-0.530 pp	-25.7%	No
Jun 2023	$207.1bn	0.479%	-0.665 pp	-27.5%	No
May 2023	$214.6bn	0.530%	-0.542 pp	-25.7%	No
Apr 2023	$218.5bn	0.738%	-0.260 pp	-18.0%	No
Mar 2023	$229.3bn	0.782%	-0.198 pp	-18.5%	No
Feb 2023	$228.0bn	0.801%	-0.114 pp	-10.6%	No
Jan 2023	$247.9bn	0.848%	-0.146 pp	-13.3%	No
Dec 2022	$287.6bn	1.038%	-0.024 pp	-10.4%	Yes
Nov 2022	$281.4bn	0.955%	-0.064 pp	-3.7%	No
Oct 2022	$261.3bn	0.927%	+0.108 pp	+9.9%	No

Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.